Skip to main content

Peginterferon Beta-1A Dosage

Medically reviewed by Drugs.com. Last updated on Jul 24, 2023.

Applies to the following strengths: 125 mcg/0.5 mL

Usual Adult Dose for Multiple Sclerosis

Day 1: 63 mcg subcutaneously
Day 15: 94 mcg subcutaneously
Day 29 and every 14 days thereafter: 125 mcg subcutaneously

Comments:


Use: For the treatment of patients with relapsing forms of multiple sclerosis (MS)

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Each hemodialysis reduces the concentration of this drug by approximately 24%.

Other Comments

Administration advice:

Patients should be advised to rotate sites for injections. The usual sites are abdomen, back of the upper arm, and thigh.

Storage requirements:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.